Serine and one-carbon metabolisms bring new therapeutic venues in prostate cancer.

Abstract

Serine and one-carbon unit metabolisms are essential biochemical pathways implicated in fundamental cellular functions such as proliferation, biosynthesis of important anabolic precursors and in general for the availability of methyl groups. These two distinct but interacting pathways are now becoming crucial in cancer, the de novo cytosolic serine pathway and the mitochondrial one-carbon metabolism. Apart from their role in physiological conditions, such as epithelial proliferation, the serine metabolism alterations are associated to several highly neoplastic proliferative pathologies. Accordingly, prostate cancer shows a deep rearrangement of its metabolism, driven by the dependency from the androgenic stimulus. Several new experimental evidence describes the role of a few of the enzymes involved in the serine metabolism in prostate cancer pathogenesis. The aim of this study is to analyze gene and protein expression data publicly available from large cancer specimens dataset, in order to further dissect the potential role of the abovementioned metabolism in the complex reshaping of the anabolic environment in this kind of neoplasm. The data suggest a potential role as biomarkers as well as in cancer therapy for the genes (and enzymes) belonging to the one-carbon metabolism in the context of prostatic cancer.

• Authors: Carlo Ganini, Ivano Amelio, Riccardo Bertolo, Eleonora Candi, Angela Cappello, Chiara Cipriani, Alessandro Mauriello, Carla Marani, Gerry Melino, Manuela Montanaro, Maria Emanuela Natale, Giuseppe Tisone, Yufang Shi, Ying Wang, Pierluigi Bove
• Journal: Discover. Oncology (Discov Oncol) Vol. 12 Issue 1 Pg. 45 (Oct 27 2021) ISSN: 2730-6011 [Electronic] United States
• PMID: 35201488 (Publication Type: Journal Article, Review)
• Copyright: © 2021. The Author(s).